an inotropic effect, increased glucose uptake, and ischemic pre-conditioning. There appears to be a GLP-1 receptor-independent effect as well, which may involve ischemic pre-conditioning and vasodilation.
Myocardial stunning is defined as the persistence of LV dysfunction after ischemia, in the absence of irreversible damage (1) . Its duration is variable, but it often persists beyond 30 min, and repeated balloon occlusions prompt additional LV dysfunction (2) .
The mechanism of this persistent dysfunction is not known; proposed mechanisms include generation of oxygen-derived free radicals (3) or calcium overload (4) . To date, no medications have proven effective in preventing this transient but potentially serious deterioration in function.
The discovery that glucagon-like peptide-1 (GLP-1) provides myocardial protection has generated significant scientific interest. GLP-1 is a 30 amino acid peptide produced in the intestinal epithelium in response to food intake (5). It is rapidly metabolized by dipeptidyl peptidase-IV (DPP-4) to its primary metabolite GLP-1(9-36), and the half-life of GLP-1 in plasma is 2 to 3 min (6). The primary action of GLP-1 is to stimulate insulin secretion and inhibit glucagon secretion, and it appears to regulate appetite and food intake (5) . In addition to pancreatic islets, the GLP-1 receptor has been identified in the brain, peripheral nervous system, intestinal tract, lung, kidney, and heart (7). Two widely used classes of type II diabetes Myocardial metabolism is a complex process and varies depending on level of stress and availability of the substrates glucose and free fatty acids (FFA) (11) . During stress, the myocardium shifts toward glucose metabolism (12) . The mechanisms by which GLP-1, its degradation-resistant analogues, and DPP-4 inhibitors provide cardioprotection are not completely understood, although at least some of this effect is thought to be via the GLP-1 receptor associated with increased myocardial glucose uptake (12) .
Recent data in a mouse model suggests 2 different GLP-1 dependent pathways of myocardial protection (13) . A GLP-1 receptor-dependent mechanism provides an inotropic effect, increased glucose uptake, and ischemic pre-conditioning. There appears to be a GLP-1 receptor-independent effect as well, which may involve ischemic pre-conditioning and vasodilation.
The primary metabolite of GLP-1, GLP-1(9-36), was 
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